Mass human exposure to rabies in New Hampshire: Exposures, treatment, and cost

被引:39
作者
Noah, DL
Smith, MG
Gotthardt, JC
Krebs, JW
Green, D
Childs, JE
机构
[1] CTR DIS CONTROL & PREVENT,NATL CTR INFECT DIS,DIV VIRAL & RICKETTSIAL DIS,ATLANTA,GA 30333
[2] BUR DIS CONTROL,DIV PUBL HLTH SERV,CONCORD,NH
关键词
D O I
10.2105/AJPH.86.8_Pt_1.1149
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objectives. This study assessed the rabies exposure and treatment that at least 665 persons in Concord, NH, received as a result of one proven rabid pet-store kitten in October 1994. Methods. All treatment recipients were interviewed by person of phone. Results. The median age of the treatment recipients was 14 years; 58% were female. The most common exposures were low risk (e.g., picking up, petting, nuzzling, or being scratched by a potentially rabid kitten). Local reactions to vaccine or immune globulin were reported by 76.5% of recipients, while 48.8% reported at least one systemic reaction, Cost for the biologicals was estimated at more than $1.1 million. Conclusions. Because of the inadequacy of pet store records, the inconsistent application of treatment guidelines, and other factors, many people received postexposure treatment as a result of contacts that were unlikely to transmit rabies. The rates of local and systemic adverse reactions experienced were consistent with previous reports.
引用
收藏
页码:1149 / 1151
页数:3
相关论文
共 14 条
[1]   REVIEW OF NON-BITE TRANSMISSION OF RABIES VIRUS-INFECTION [J].
AFSHAR, A .
BRITISH VETERINARY JOURNAL, 1979, 135 (02) :142-148
[2]  
ANDERSON LJ, 1980, JAMA-J AM MED ASSOC, V244, P781
[3]   POSTEXPOSURE TRIAL OF A HUMAN-DIPLOID CELL STRAIN RABIES VACCINE [J].
ANDERSON, LJ ;
SIKES, RK ;
LANGKOP, CW ;
MANN, JM ;
SMITH, JS ;
WINKLER, WG ;
DEITCH, MW .
JOURNAL OF INFECTIOUS DISEASES, 1980, 142 (02) :133-138
[4]  
ANDERSON LJ, 1980, P 11 ICC 19 ICAAC AM, P1357
[5]   NEUROPARALYTIC ILLNESS AND HUMAN-DIPLOID CELL RABIES VACCINE [J].
BERNARD, KW ;
SMITH, PW ;
KADER, FJ ;
MORAN, MJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1982, 248 (23) :3136-3138
[6]   GUILLAIN-BARRE-SYNDROME AFTER VACCINATION WITH HUMAN-DIPLOID CELL RABIES VACCINE [J].
BOE, E ;
NYLAND, H .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1980, 12 (03) :231-232
[7]   HUMAN-DIPLOID CELL RABIES VACCINE PURIFIED BY ZONAL CENTRIFUGATION - A CONTROLLED-STUDY OF ANTIBODY-RESPONSE AND SIDE-EFFECTS FOLLOWING PRIMARY AND BOOSTER PRE-EXPOSURE IMMUNIZATIONS [J].
FISHBEIN, DB ;
DREESEN, DW ;
HOLMES, DF ;
PACER, RE ;
LEY, AB ;
YAGER, PA ;
SUMNER, JW ;
REIDSANDEN, FL ;
SANDERLIN, DW ;
TONG, TC ;
KEMP, DT .
VACCINE, 1989, 7 (05) :437-442
[8]  
KNITTEL T, 1989, LANCET, V1, P1334
[9]  
*PHS, 1990, DHHS PUBL PHS, P122
[10]   GUILLAIN-BARRE-SYNDROME FOLLOWING VACCINATION IN THE NATIONAL-INFLUENZA-IMMUNIZATION-PROGRAM, UNITED-STATES, 1976-1977 [J].
SCHONBERGER, LB ;
BREGMAN, DJ ;
SULLIVANBOLYAI, JZ ;
KEENLYSIDE, RA ;
ZIEGLER, DW ;
RETAILLIAU, HF ;
EDDINS, DL ;
BRYAN, JA .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1979, 110 (02) :105-123